661 related articles for article (PubMed ID: 26641892)
1. Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.
Shi J; Zhang J; Li S; Sun J; Teng Y; Wu M; Li J; Li Y; Hu N; Wang H; Hu Y
PLoS One; 2015; 10(12):e0144475. PubMed ID: 26641892
[TBL] [Abstract][Full Text] [Related]
2. CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice.
Veit S; Jany S; Fux R; Sutter G; Volz A
Viruses; 2018 Dec; 10(12):. PubMed ID: 30558354
[TBL] [Abstract][Full Text] [Related]
3. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
[TBL] [Abstract][Full Text] [Related]
4. Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study.
Tahir Ul Qamar M; Saleem S; Ashfaq UA; Bari A; Anwar F; Alqahtani S
J Transl Med; 2019 Nov; 17(1):362. PubMed ID: 31703698
[TBL] [Abstract][Full Text] [Related]
5. A Computational Vaccine Designing Approach for MERS-CoV Infections.
Ibrahim HS; Kafi SK
Methods Mol Biol; 2020; 2131():39-145. PubMed ID: 32162250
[TBL] [Abstract][Full Text] [Related]
6. Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach.
Mahmud S; Rafi MO; Paul GK; Promi MM; Shimu MSS; Biswas S; Emran TB; Dhama K; Alyami SA; Moni MA; Saleh MA
Sci Rep; 2021 Jul; 11(1):15431. PubMed ID: 34326355
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
[TBL] [Abstract][Full Text] [Related]
8. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
[TBL] [Abstract][Full Text] [Related]
9. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
[TBL] [Abstract][Full Text] [Related]
10. Prospects for a MERS-CoV spike vaccine.
Zhou Y; Jiang S; Du L
Expert Rev Vaccines; 2018 Aug; 17(8):677-686. PubMed ID: 30058403
[TBL] [Abstract][Full Text] [Related]
11. Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus.
Guo X; Deng Y; Chen H; Lan J; Wang W; Zou X; Hung T; Lu Z; Tan W
Immunology; 2015 Aug; 145(4):476-84. PubMed ID: 25762305
[TBL] [Abstract][Full Text] [Related]
12. Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus.
Deng Y; Lan J; Bao L; Huang B; Ye F; Chen Y; Yao Y; Wang W; Qin C; Tan W
Emerg Microbes Infect; 2018 Apr; 7(1):60. PubMed ID: 29618723
[TBL] [Abstract][Full Text] [Related]
13. Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus.
Kim MH; Kim HJ; Chang J
PLoS One; 2019; 14(7):e0220196. PubMed ID: 31329652
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
[TBL] [Abstract][Full Text] [Related]
15. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
Jiaming L; Yanfeng Y; Yao D; Yawei H; Linlin B; Baoying H; Jinghua Y; Gao GF; Chuan Q; Wenjie T
Vaccine; 2017 Jan; 35(1):10-18. PubMed ID: 27899228
[TBL] [Abstract][Full Text] [Related]
16. Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.
Wang Y; Tai W; Yang J; Zhao G; Sun S; Tseng CK; Jiang S; Zhou Y; Du L; Gao J
Hum Vaccin Immunother; 2017 Jul; 13(7):1615-1624. PubMed ID: 28277821
[TBL] [Abstract][Full Text] [Related]
17. MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques.
Wang C; Zheng X; Gai W; Zhao Y; Wang H; Wang H; Feng N; Chi H; Qiu B; Li N; Wang T; Gao Y; Yang S; Xia X
Oncotarget; 2017 Feb; 8(8):12686-12694. PubMed ID: 27050368
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
[TBL] [Abstract][Full Text] [Related]
19. [Bioinformatics-based Design of Peptide Vaccine Candidates Targeting Spike Protein of MERS-CoV and Immunity analysis in Mice].
Lan J; Lu S; Deng Y; Wen B; Chen H; Wang W; Tan W
Bing Du Xue Bao; 2016 Jan; 32(1):77-81. PubMed ID: 27295887
[TBL] [Abstract][Full Text] [Related]
20. Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus.
Tang J; Zhang N; Tao X; Zhao G; Guo Y; Tseng CT; Jiang S; Du L; Zhou Y
Hum Vaccin Immunother; 2015; 11(5):1244-50. PubMed ID: 25874632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
